BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11097780)

  • 21. Evaluation of endocrine profile, hypothalamic-pituitary-testis axis and semen quality in multiple sclerosis.
    Safarinejad MR
    J Neuroendocrinol; 2008 Dec; 20(12):1368-75. PubMed ID: 19094084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update.
    Petak SM; Nankin HR; Spark RF; Swerdloff RS; Rodriguez-Rigau LJ;
    Endocr Pract; 2002; 8(6):440-56. PubMed ID: 15260010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hypogonadotrophic hypogonadism with pulsatile GnRH therapy].
    von Zumbusch R; Vogt HJ
    Hautarzt; 1993 Jan; 44(1):46-8. PubMed ID: 8436510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of immunisation against gonadotrophin releasing hormone isoforms (mammalian GnRH-I, chicken GnRH-II and lamprey GnRH-III) on murine spermatogenesis.
    Khan MA; Prevost M; Waterston MM; Harvey MJ; Ferro VA
    Vaccine; 2007 Mar; 25(11):2051-63. PubMed ID: 17240004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gonadotrophin replacement for induction of fertility in hypogonadal men.
    Dwyer AA; Raivio T; Pitteloud N
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):91-103. PubMed ID: 25617175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testicular suspension as a method of male contraception: technique and results.
    Shafik A
    Adv Contracept Deliv Syst; 1991; 7(3-4):269-79. PubMed ID: 12284770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feedback inhibition of gonadotropins by testosterone in men with hypogonadotropic hypogonadism: comparison to the intact pituitary-testicular axis in primary hypogonadism.
    Shimon I; Lubina A; Gorfine M; Ilany J
    J Androl; 2006; 27(3):358-64. PubMed ID: 16474013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic testing in the evaluation of male gonadal function.
    De Martino MU; Pastore R; Caprio M; Frajese G; Fabbri A
    J Endocrinol Invest; 2003; 26(7 Suppl):107-13. PubMed ID: 14604073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Male pubertal development and the role of androgen therapy.
    Richmond EJ; Rogol AD
    Nat Clin Pract Endocrinol Metab; 2007 Apr; 3(4):338-44. PubMed ID: 17377616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Physiology of puberty. Endocrine aspects].
    Olivier G
    Union Med Can; 1974 Mar; 103(3):511-6. PubMed ID: 4820883
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of the buserelin stimulation test in diagnosing gonadotropin deficiency in males with delayed puberty.
    Wilson DA; Hofman PL; Miles HL; Unwin KE; McGrail CE; Cutfield WS
    J Pediatr; 2006 Jan; 148(1):89-94. PubMed ID: 16423605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypothalamic expression of human growth hormone induces post-pubertal hypergonadotrophism in male transgenic growth retarded rats.
    Davies JS; Thompson NM; Christian HC; Pinilla L; Ebling FJ; Tena-Sempere M; Wells T
    J Neuroendocrinol; 2006 Oct; 18(10):719-31. PubMed ID: 16965290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review on testicular development, structure, function, and regulation in common marmoset.
    Li LH; Donald JM; Golub MS
    Birth Defects Res B Dev Reprod Toxicol; 2005 Oct; 74(5):450-69. PubMed ID: 16193499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypothalamic and hypophyseal hypogonadism in males].
    Nieschlag E; Brabant G
    Verh Dtsch Ges Inn Med; 1980; 86():83-93. PubMed ID: 6784374
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of gonadotropin releasing hormone in normal and pathologic endocrine processes.
    Rothman MS; Wierman ME
    Curr Opin Endocrinol Diabetes Obes; 2007 Aug; 14(4):306-10. PubMed ID: 17940457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of disease: late-onset hypogonadism.
    Mahmoud A; Comhaire FH
    Nat Clin Pract Urol; 2006 Aug; 3(8):430-8. PubMed ID: 16902519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testicular findings, endocrine features and therapeutic responses of men with acquired hypogonadotropic hypogonadism.
    Tachiki H; Ito N; Maruta H; Kumamoto Y; Tsukamoto T
    Int J Urol; 1998 Jan; 5(1):80-5. PubMed ID: 9535606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Male infertility: non-surgical therapy].
    Gulino G; Stefanucci M; Antonucci M; Racioppi M; Sacco E; Pinto F; Bassi PF
    Urologia; 2014; 81(3):148-53. PubMed ID: 25198940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idiopathic hypogonadotropic hypogonadism in selective human gonadotropin deficiency in adult man: a case report.
    Volpi R; Ugolotti MC; Carbucicchio A; Delsignore R
    Acta Biomed; 2008 Dec; 79(3):251-4. PubMed ID: 19260388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leydig cell micronodules are a common finding in testicular biopsies from men with impaired spermatogenesis and are associated with decreased testosterone/LH ratio.
    Holm M; Rajpert-De Meyts E; Andersson AM; Skakkebaek NE
    J Pathol; 2003 Mar; 199(3):378-86. PubMed ID: 12579540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.